Radiotherapy

1.Basic situation: The Department of Radiation Oncology was formally established in January 2006. 2.Bed capacity: There are currently 6 beds. 3.Personnel team: There are currently 16 medical and nursing personnel, including 4 physicians, 2 chief physicians and associate chief physicians in total, 1 attending physician, and 1 resident physician. Among them, 1 person holds a master's degree and 1 person holds a doctoral degree. 4.Equipment configuration: A German Siemens high-energy linear accelerator and its supporting built-in multileaf collimator (MLC), the American Odyssey and Philips Pinnacle3 treatment planning systems (TPS) for treatment planning, X-ray simulation positioning equipment for tumor localization, etc.; instruments for dose measurement and quality assurance include an electronic portal imaging device (EPID), a German IBA dosimeter, an American MapCHECK 1175 dose distribution map detector, an American isocenter calibrator, simulated water material (solid water), general-purpose IMRT verification phantoms, etc. 5.Clinical features: The department mainly conducts radical radiotherapy, comprehensive treatment combined with other therapies (such as chemotherapy, biological and targeted therapy), or palliative radiotherapy to relieve symptoms for various tumors, including nasopharyngeal carcinoma, laryngeal cancer, tonsillar cancer and other head and neck cancers, thoracic tumors such as esophageal cancer and lung cancer, breast cancer, brain and spinal cord tumors, liver cancer, pancreatic cancer, hematological tumors such as malignant lymphoma, skin cancer, soft tissue sarcoma, tumors of the male and female reproductive systems, and rectal cancer. 6.Scientific research and teaching: In recent years, the department has applied for 1 district-level project, project number: JL201808, and has published 2 SCI papers in the past 5 years. Multiple staff members have served as committee members in provincial- and municipal-level medical associations and physicians' associations.